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Abstract
Background: Despite the initial promise of myoblast transfer therapy to restore dystrophin in Duchenne muscular
dystrophy patients, clinical efficacy has been limited, primarily by poor cell survival post-transplantation. Murine muscle
derived stem cells (MDSCs) isolated from slowly adhering cells (SACs) via the preplate technique, induce greater muscle
regeneration than murine myoblasts, primarily due to improved post-transplantation survival, which is conferred by their
increased stress resistance capacity. Aldehyde dehydrogenase (ALDH) represents a family of enzymes with important
morphogenic as well as oxidative damage mitigating roles and has been found to be a marker of stem cells in both normal
and malignant tissue. In this study, we hypothesized that elevated ALDH levels could identify murine and human muscle
derived cell (hMDC) progenitors, endowed with enhanced stress resistance and muscle regeneration capacity.
Methodology/Principal Findings: Skeletal muscle progenitors were isolated from murine and human skeletal muscle by a
modified preplate technique and unfractionated enzymatic digestion, respectively. ALDH
hi subpopulations isolated by
fluorescence activate cell sorting demonstrated increased proliferation and myogenic differentiation capacities compared to
their ALDH
lo counterparts when cultivated in oxidative and inflammatory stress media conditions. This behavior correlated
with increased intracellular levels of reduced glutathione and superoxide dismutase. ALDH
hi murine myoblasts were
observed to exhibit an increased muscle regenerative potential compared to ALDH
lo myoblasts, undergo multipotent
differentiation (osteogenic and chondrogenic), and were found predominately in the SAC fraction, characteristics that are
also observed in murine MDSCs. Likewise, human ALDH
hi hMDCs demonstrated superior muscle regenerative capacity
compared to ALDH
lo hMDCs.
Conclusions: The methodology of isolating myogenic cells on the basis of elevated ALDH activity yielded cells with
increased stress resistance, a behavior that conferred increased regenerative capacity of dystrophic murine skeletal muscle.
This result demonstrates the critical role of stress resistance in myogenic cell therapy as well as confirms the role of ALDH as
a marker for rapid isolation of murine and human myogenic progenitors for cell therapy.
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Introduction
Duchenne muscular dystrophy is a degenerative muscle disease
caused by a mutation of the gene encoding dystrophin, a protein
that anchors the myofiber cytoskeleton to the basal lamina,
resulting in muscle fiber necrosis and progressive weakness [1,2].
Despite extensive investigation of various approaches to deliver
dystrophin to dystrophic muscle, few treatment options for patients
with this devastating disease exist [3,4]. Myoblast transfer therapy,
defined as the transplantation of normal myoblasts into dystro-
phin-deficient muscle, has been shown to transiently deliver
dystrophin to dystrophic myofibers as well as improve muscle
contraction force [5]. However outcomes of this approach are
limited by immune rejection, limited cell migration with the
formation of cell pockets, and poor cell survival rates, which is
perhaps the most important barrier to efficacious myogenic cell
therapy [6,7,8]. Pursuit of novel myogenic progenitors and
delivery approaches that would mitigate this cell loss are active
areas of research [9,10,11,12].
Numerous myogenic progenitors have been isolated from post-
natal murine and human skeletal muscle for cell therapy such as
satellite cells, myoblasts, MDSCs, side-population cells, Sk-DN/
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+ cells, and
myo-endothelial cells [5,13,14,15,16]. Some of these myogenic cell
types have demonstrated excellent muscle regeneration capacities
in vivo; however, in our experience the common behavior of
myogenic progenitors that induce robust muscle regeneration is
their increased capacity to withstand oxidative and inflammatory
stress [9,10,11]. The muscle derived stem cell (MDSC), a
myogenic progenitor isolated from the slowly adhering fraction
of the preplate technique, has been shown to induce greater
skeletal muscle regeneration than myoblasts largely due to their
increased capacity to resist oxidative stress [9,17]. This stress
resistance capacity is necessary to survive, proliferate, and
differentiate under conditions of inflammation, an environment
of oxidative and inflammatory stress that causes a precipitous loss
in transplanted cell viability [18,19,20,21].
Previously we demonstrated the central role that the intracel-
lular antioxidant glutathione (GSH) plays in the increased survival
and muscle regenerative capacity of MDSCs. Increased levels of
GSH in MDSCs compared to myoblasts was correlated with the
increased rates of survival, proliferation, and myogenic differen-
tiation in conditions of oxidative and inflammatory stress [9].
When the GSH levels of MDSCs were reduced using diethyl
maleate (DEM) to levels that are observed in myoblasts, a
significant reduction in the ability of MDSCs to regenerate skeletal
and cardiac muscle was observed [9]. In fact, the regeneration
capacity of the MDSCs with diminished GSH levels was
statistically equivalent to that observed in myoblasts. In contrast,
by increasing the GSH levels of MDSCs using n-acetylcysteine
treatment, the cardiac and skeletal muscle regeneration was
significantly improved compared to untreated MDSCs [11]. These
studies led us to hypothesize that the muscle regenerative capacity
of a myogenic cell is primarily determined by its capacity to
withstand oxidative and inflammatory stress, rather than the
extent of its stem cell-like characteristics such as self-renewal and
multilineage differentiation potential. In fact, other groups have
suggested that increased stress resistance may be a primary
characteristic of stemness for a variety of stem cell populations
[22,23,24,25].
In the current study, we sought to further validate this
hypothesis through the isolation of myogenic progenitors with
enhanced stress resistance using elevated expression of cytosolic
aldehyde dehydrogenase (ALDH1A1) as a marker for this trait.
ALDH represents a family of intracellular enzymes that regulate
retinoic acid (RA) concentration, which plays an important role in
embryonic myogenesis, by driving the expression of multiple
myogenic regulatory factors (MRFs) in murine and human
embryonic stem cells [26,27,28,29]. ALDH activity has been used
to identify and sort primitive progenitors from multiple tissues
[30]. Elevated aldehyde dehydrogenase (ALDH) has been shown
to be a marker of progenitor status in hematopoietic [31,32],
mesenchymal [33], endothelial [34], neural [35,36], and recently
human skeletal muscle cell populations [16,37], as well as being a
marker of cancer stem cells or metastasis competent tumor cells
[38]. Perhaps more importantly, ALDH activity has been shown
to directly mitigate oxidative damage by converting aldehyde by-
products of lipid peroxidation to non-reactive carboxylic acids and
has been associated with other mechanisms of increased
antioxidant capacity in somatic and cancer stem cells [39,40,41].
For example, hematopoietic stem cells present upregulated FoxO
(Forkhead O) transcription factors, downstream targets of the
PI3K-AKT pathway and regulators of the oxidative stress
response, which include induction of MnSOD, catalase, and
GADD45 [42,43]. Endothelial progenitors isolated from umbilical
cord blood present elevated MnSOD levels that significantly
increase their oxidative stress resistance and effectiveness in
treating tissue ischemia [44,45]. Similar properties of increased
expression of free radical scavenging systems and decreased levels
of reactive oxygen species is observed in epithelial breast cancer
stem cells [46,47,48].
Subpopulations of skeletal muscle derived cells that expressed
high and low levels of ALDH (ALDH
hi and ALDH
lo) were isolated
from cultured murine and human skeletal muscle by fluorescence
activated cell sorting (FACS) as depicted in Figure S1. These
ALDH
lo and ALDH
hi subpopulations were isolated from preplate
derived murine myoblasts and MDSCs in addition to unfraction-
ated human muscle derived cells (hMDCs) [12]. The capacity of
ALDH
lo and ALDH
hi populations to withstand oxidative and
inflammatory stress conditions, in terms of proliferation and
myogenic differentiation, was examined in addition to their
skeletal muscle regeneration capacity in vivo. This stress resistance
capacity was then correlated with intracellular antioxidant levels,
in the form of GSH and superoxide dismutase (SOD). Observa-
tions of increased ALDH activity in human muscle derived cells
have been made previously by Jean et al. and Vauchez et al., who
demonstrated the myogenic capacity of these subpopulations both
in vitro and in vivo [16,37]. Jean et al. also observed an increased
survival capacity of ALDH
hi human myoblasts when exposed to
H2O2 in vitro, yet found no analogous ALDH
hi subpopulation in
murine muscle isolates [37]. However, differences in our
observations may be attributed to differences in our isolation
protocol, which is addressed in the discussion section. Further, we
studied the multilineage differentiation potential of murine
ALDH
hi myoblasts in vitro, by comparing the osteogenic and
chondrogenic potential of ALDH
hi to that of ALDH
lo myoblasts.
A summary of the findings described in the present study can be
found in the Table S1. Our results suggest that increased ALDH
activity identifies myogenic progenitors in both murine and
human skeletal muscle with increased oxidative and inflammatory
stress resistance capacity. Furthermore, these results highlight the
important role of stress resistance in stem cell mediated muscle
regenerative therapies.
Results
Isolation of ALDH
lo and ALDH
hi populations of skeletal
muscle derived cells
Cells with elevated ALDH levels become fluorescent when
exposed to boron-dipyrromethene (BODIPY) labeled amino
acetaldehyde (Aldefluor, StemCell Technologies) and can be
isolated using fluorescence activated cell sorting (FACS). The non-
polar BODIPY-aminoacetaldehyde diffuses freely into the cyto-
plasm and is converted by cytosolic ALDH1A1 to the negatively
charged BODIPY-aminoacetate, which accumulates in the
cytoplasm and causes the cell to fluoresce with an emission peak
at 513 nm [49]. Cells, of low side scatter, whose brightness
exceeded the gated intensity of the diethylaminobenzaldehyde
(DEAB) inhibited population were deemed ALDH
hi and isolated
from heterogeneous populations of murine and human muscle
derived cells.
ALDH
hi cell subpopulations were isolated from rapidly
adhering preplate myoblasts, slowly adhering MDSCs as well as
unfractionated hMDCs [12]. Figure 1 illustrates a representative
FACS isolation of ALDH
hi and ALDH
lo subpopulations of murine
myoblasts. Dead cells were excluded from FACS isolations by
detection of nuclear propidium iodide staining (Figure 1a). The
gating for ALDH
hi and ALDH
lo cell isolations were determined by
ALDH fluorescence extremes of DEAB inhibited controls (and low
side scatter) of each population as illustrated in Figure 1b. ALDH
lo
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hi myoblasts represented roughly 1–5% of the total
myoblast population (Figure 1c).
We observed an elevated median Aldefluor fluorescence in
murine MDSCs compared to myoblasts, despite the absence of a
difference in autofluorescence in their untreated controls (data not
shown). In addition, MDSCs appear to have a more homogenous
elevated ALDH activity than myoblasts, indicating less heteroge-
neity in ALDH expression. The red overlay in Figure 1d indicates
a trend of increased stress resistance observed in MDSCs
compared to myoblasts and is intended to emphasize the increase
in stress resistance that we observed in cells with elevated ALDH
activity. It should also be noted that we typically observed
increased cell viability in ALDH
hi cells compared to ALDH
lo cells
immediately following FACS isolation (data not shown). That is,
the mechanical stress of the cell segregation process of flow
cytometry typically had a more deleterious effect on the ALDH
lo
cell viability compared to the ALDH
hi cells.
To verify this trend of increased ALDH activity in slowly
adhering MDSCs, the preplate technique was performed using
ALDH
lo and ALDH
hi cells isolated from dissociated murine
skeletal muscle (Figure 1e). A trend of increased numbers of
preplate SACs (PP3 and beyond) was obtained by preplating
ALDH
hi cells, when compared to performing the preplate
technique on ALDH
lo cells. However it is possible that fewer
SACs were obtained from the ALDH
lo subpopulation, compared
to the ALDH
hi subpopulation simply due to the decreased viability
of ALDH
lo cells following the cumulative cellular damage of
enzymatic digestion and FACS isolation. We attribute the paucity
of cells in preplate populations PP5 and beyond to these stressors
in addition to the necessary delay in initiating the preplate process.
However it should be noted that variability in late preplate yield
(PP5 and PP6) has been observed in previous studies despite the
consistent observation of enrichment in the MDSC population in
successive preplate cycles beyond PP2 [12].
Increased stress resistance, proliferation, differentiation
and muscle regeneration capacity of ALDH
hi sorted
murine myoblasts
Myoblasts isolated from rapidly adhering cells (RACs) using the
preplate technique have been previously characterized as a
heterogeneous population in various states of quiescence, activa-
tion, and differentiation [17,50,51]. We therefore hypothesized
that we may also observe heterogeneity in their ALDH expression.
ALDH
lo and ALDH
hi subpopulations of murine myoblasts were
isolated by FACS as depicted in Figure 2a. FACS gating was set
using DEAB inhibition of ALDH activity as described previously
and illustrated in Figure 2b.
Following FACS isolation of ALDH
lo and ALDH
hi subpopu-
lations from the RACs, we quantified the oxidative (hydrogen
Figure 1. Fluorescence activated cell sorting (FACS) of muscle derived cells by aldehyde dehydrogenase activity. Isolation of ALDH
lo
and ALDH
hi subpopulations from cultured myoblasts was performed using FACS. (a) Dead cells were excluded from the isolation by detection of
nuclear propidium iodide fluorescence. (b, c) ALDH
hi SCC
lo (high ALDH activity, low side scatter) cells were isolated from a heterogeneous population
of myoblasts using DEAB, a potent inhibitor of ALDH, as a gating control. (d) Measurement of the FITC channel signal intensity of Aldefluor stained
murine myoblasts and MDSCs demonstrated a shift in the distribution of signal intensity between the two populations, suggesting an increase in the
median ALDH activity in MDSCs compared to myoblasts. (e) ALDH sorted murine muscle derived cells were preplated to demonstrate the increased
yield of cells in later preplate cycles from ALDH
hi cells (up to PP5) compared to ALDH
lo cells. Cells were isolated from three mice labeled m1, m2, and
m3. (* indicates p,0.05).
doi:10.1371/journal.pone.0029226.g001
Aldehyde Dehydrogenase in Muscle Progenitors
PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e29226Figure 2. Isolation and stress resistance capacity of ALDH
hi myoblasts. (a, b) ALDH
hi murine myoblasts were isolated via fluorescence
activated cell sorting (FACS) from a heterogeneous population of skeletal muscle derived cells using DEAB, a potent inhibitor of ALDH, as a gating
control. (c, d) A significantly increased rate of proliferation of ALDH
hi myoblasts compared to ALDH
lo myoblasts was observed in conditions of
oxidative stress (H2O2, 250 mM) (* indicates p,0.05) and inflammatory stress conditions (TNF-a, 2.5 ng/ml) (n=9). (e) ALDH
lo and ALDH
hi myoblasts
underwent myogenic differentiation by fusing into MHC+ myotubes (red) under oxidative stress conditions (H2O2, 250 mM). Nuclei were stained with
DAPI (blue). (f) Significantly increased myogenic differentiation indices (MDI) were observed in ALDH
hi cells at several concentrations of oxidative
stress (0, 250 and 500 mM) when compared to ALDH
lo (n=3). (g) Similarly increased MDIs of ALDH
hi cells were observed under all inflammatory stress
conditions when compared to ALDH
lo myoblasts. (h) An increased number and density of dystrophin positive myofibers (stained in red) were
observed in mdx mice injected intramuscularly with ALDH
hi cells compared to those injected with ALDH
lo myoblasts. Nuclei are DAPI (blue) stained.
Green FluoSphere beads are observed to localize at the area of initial injection. (i) A significantly increased regeneration index was observed in
ALDH
hi transplanted mice compared to those injected with ALDH
lo and unsorted cells. (n=3) (j, k) Measurements of intracellular antioxidants
glutathione (GSH) and superoxide dismutase (SOD) levels demonstrated statistically significant elevation of both antioxidants in ALDH
hi myoblasts
compared to ALDH
lo myoblasts (n=3).
doi:10.1371/journal.pone.0029226.g002
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these subpopulations during proliferation and myogenic differen-
tiation [52]. Hydrogen peroxide is a strong oxidant that is formed
by the dismutation of superoxide and freely diffuses across the cell
membrane. TNF-a on the other hand is an acute phase cytokine
that has been shown to inhibit myogenic differentiation via NF-kB
induction, promote caspase mediated apoptosis, and induce
reactive oxygen species accumulation in mitochondria [53,54].
Significant differences in stress resistance capacity were
observed between ALDH
lo and ALDH
hi subpopulations of murine
myoblasts in terms of proliferation and myogenic differentiation.
The quantification of proliferation rates of ALDH
lo and ALDH
hi
myoblasts was performed using live cell imaging microscopy in
conditions of oxidative and inflammatory stress. This study
showed a significant proliferation advantage by the ALDH
hi cells
compared to ALDH
lo cells (Figure 2c,d). The myogenic differen-
tiation capacity was quantified using the myogenic differentiation
index (MDI), a measure of the ratio of nuclei in myosin heavy
chain (MHC) expressing myofibers to total number of nuclei as
defined previously [55]. Myogenic differentiation of ALDH
lo and
ALDH
hi myoblasts was induced by a 4d exposure to low serum
(2% horse serum) differentiation medium (DM) conditions in the
presence of oxidative and inflammatory stress (Figure 2e-g). A
significantly increased proportion of MHC expressing cells was
observed in ALDH
hi myoblasts compared to ALDH
lo myoblasts
(Figure 2e-g), indicating that ALDH
hi myoblasts not only preserve
their competence for proliferation but also differentiation under
oxidative and inflammatory stress conditions more effectively than
ALDH
lo myoblasts.
ALDH
hi and ALDH
lo murine myoblasts were injected intra-
muscularly into the gastrocnemius of mdx mice to determine the
degree of muscle regeneration in vivo. Muscles were excised and
frozen for immunohistochemical characterization after a period of
14 days post-transplantation. The cell transplantations yielded
regeneration of dystrophin (DYS) expressing myofibers
(Figure 2h,i). The extent of myofiber formation was quantified
using the regeneration index (RI) metric, a measure of DYS
+
myofibers in cryosectioned mdx muscle per 10
5 cells injected, as
described previously [9]. Significantly greater RIs were observed
in the muscles injected with ALDH
hi myoblasts compared to
ALDH
lo myoblasts, suggesting that the regeneration index
observed in vivo correlates with the stress resistance results
obtained in vitro.
To further characterize the increased stress resistance capacity
of the ALDH
hi myoblasts, we examined two major intracellular
antioxidants, GSH and SOD. Significantly increased concentra-
tions of GSH and increased activity of SOD was observed in
ALDH
hi myoblasts compared to ALDH
lo myoblasts using
spectrophotometric assays (Figure 2j,k). The association of
elevated ALDH activity with elevated intracellular antioxidant
levels suggests a potential mechanism by which these ALDH
hi cells
are able to better withstand oxidative and inflammatory stress
conditions in vitro and after implantation in vivo when compared
to their ALDH
lo counterparts.
The role of antioxidants and the ALDH enzyme in the
stress resistance of ALDH
hi murine myoblasts
To further elucidate the role of intracellular antioxidant levels in
the stress resistance capacity of ALDH sorted myoblasts, we
altered the cells antioxidant levels prior to oxidative stress
challenge. ALDH
lo myoblasts were treated with a mitochondrial
targeted antioxidant, XJB-5-131 (XJB) prior to exposure to
hydrogen peroxide to determine whether the proliferation rate
could be elevated to that of ALDH
hi cells [56]. On the other hand
ALDH
hi myoblasts were treated with a GSH sequestrator, DEM,
prior to oxidative stress exposure in order to alter their
intracellular antioxidant levels [57].
Alteration of the antioxidant levels of these ALDH subpop-
ulations had a significant impact on their proliferation capacities
in oxidative stress. In contrast to the decreased proliferative
capacity of ALDH
lo murine myoblasts compared to ALDH
hi
myoblasts seen in Figure 2b, when the antioxidant levels of
ALDH
lo cells were increased with XJB (500 nM) prior to
oxidative stress exposure, the proliferation rate was significantly
increased, to a level statistically equivalent to that observed in
the ALDH
hi myoblasts (Figure 3b). On the other hand, when the
antioxidant levels of ALDH
hi myoblasts were decreased by
treatment with DEM (50 mM), the proliferation rate was
significantly decreased to that observed in the ALDH
lo myoblasts
(Figure 3a). This result suggests that the differences in stress
resistance between the ALDH
hi and ALDH
lo myoblasts is
conferred by differences in their oxidative stress handling
capacities, which can be readily modified using antioxidant
and pro-oxidant treatment.
Given the role of antioxidant activity in the stress resistance of
ALDH
hi myoblasts, we questioned whether the ALDH enzyme
was directly participating in the oxidative stress resistance of
ALDH
hi myoblasts. ALDH has been directly implicated in the
mitigation of oxidative damage by converting aldehyde by-
products of lipid peroxidation such as malenaldehyde to non-
reactive carboxylic acids [39,41]. Furthermore, in the course of
this reaction, the cofactor NADP
+ is reduced to NADPH, which in
turn may be oxidized in the process of GSH recycling via
glutathione reductase. We hypothesized that ALDH activity may
be directly responsible for the elevated oxidative stress resistance of
ALDH
hi myoblasts, as found by Jean et al. [37,58]. However,
when we treated the ALDH
hi cells with DEAB (50 mM), a potent
inhibitor of ALDH, we observed that DEAB impaired ALDH
hi
myoblast proliferation in the absence of oxidative stress (Figure 3c),
yet had no effect on the proliferation rate of ALDH
hi cells in
oxidative stress conditions (250 mMH 2O2) except at a single time
point, 24 hrs (Figure 3d). This result suggests that ALDH
antioxidant activity is not essential for the increased antioxidant
capacity of murine ALDH
hi myoblasts.
Increased chondrogenic and osteogenic differentiation
potential of ALDH
hi myoblasts
It is well known that RA, a product of ALDH mediated
oxidation of retinal, is required for embryonic myogenesis and can
accelerate differentiation in postnatal derived myoblasts [27,59].
RA works synergistically with bone morphogenic protein to
promote osteogenesis, however its role in chondrogenesis is
primarily inhibitory although it may be required at specific stages
of differentiation [60,61,62,63]. However, one may also consider
the media conditions that are required to induce these differen-
tiation pathways are deleterious to cells and represent a form of
stress. For example one may consider the low serum conditions of
myogenic differentiation medium as another kind of stress
condition, which has been shown to induce apoptosis in those
myoblasts that fail to upregulate p21 and Rb [64,65]. Perhaps the
cells’ capacity to survive and function normally in adverse or
altered media conditions is a necessary precondition to differen-
tiate. We therefore hypothesized that elevated ALDH expression
and stress resistance capacity could also favor osteogenic and
chondrogenic differentiation in vitro.
We studied the chondrogenic and osteogenic differentiation of
ALDH sorted myoblasts and found that, ALDH
hi myoblasts
demonstrate a greater capacity to undergo chondrogenic and
Aldehyde Dehydrogenase in Muscle Progenitors
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lo
myoblasts (Figure 4). When chondrogenic differentiation was
induced via a pellet system containing TGF-beta, rapid
proliferation and chondrogenic pellet formation was observed
in ALDH
hi myoblasts after 24 hrs with robust production
glycosaminoglycans (GAGs, visualized via Alcian blue staining)
(Figure 4b). This behavior mirrors that of the unsorted myoblasts
(Figure 4a) suggesting that the chondrogenic potential of unsorted
myoblasts may be conferred primarily by the ALDH
hi myoblasts
(Figure 4b). However ALDH
lo myoblasts demonstrated poor
proliferation in chondrogenic media and formed smaller, less
dense pellets that required 2–3 d to coalesce (Figure 4c). Even
after 21 d of culture, increased cell density and GAG formation
was observed in ALDH
hi myoblasts compared to ALDH
lo
myoblasts (Figure 4d–f).
Osteogenic differentiation of murine myoblasts was induced
via bone morphogenic protein-4 (BMP-4) stimulation. The
unsorted myoblast population increased their alkaline phospha-
tase expression, an early marker of osteogenic differentiation, in
response to BMP-4 stimulation (Figure 4d), which was also
observed in ALDH
hi myoblasts (Figure 4e). However a low
alkaline phosphatase expression was observed in ALDH
lo
myoblasts following BMP-4 stimulation (Figure 4f). As was
observed in chondrogenic media conditions, the osteogenic
differentiation potential of unsorted myoblasts appeared to be
primarily due to the differentiation activity of ALDH
hi myoblasts
(Figure 4d–f).
While the differences in osteogenic differentiation in ALDH
sorted myoblasts may either be attributed to increased osteogenic
capacity or increased media stress resistance, the case of
chondrogenic differentiation capacity suggests the latter mecha-
nism. It seems clear that ALDH
lo myoblasts experienced some
form of growth retardation in chondrogenic media compared to
ALDH
hi myoblasts to the extent that ALDH
lo myoblasts did not
form a condensed pellet. Furthermore increased RA production
by the ALDH
hi cell would not be expected to increase the
chondrogenic differentiation capacity of these cells. The inability
of ALDH
lo myoblasts to survive and proliferate in chondrogenic
media impaired their capacity for chondrogenic differentiation, as
measured by pellet size and amount of GAG production.
Consequently, we believe that the increased proliferation potential
of ALDH
hi myoblasts may not only improve the myogenic
differentiation but also facilitate increased chondrogenic and
osteogenic differentiation capacities.
Figure 3. The role of antioxidants and ALDH in the stress resistance of murine ALDH
hi myoblasts. (a) When the antioxidant levels of
ALDH
hi myoblasts were decreased by treatment with diethyl maleate (DEM), their proliferation rate was decreased to that of ALDH
lo myoblasts (n=5).
(* indicates p,0.05 at a given timepoint.) (b) By increasing the antioxidant levels of ALDH
lo cells with XJB prior to oxidative stress (H2O2, 250 mM)
exposure, the proliferation rate in oxidative stress was increased to the levels observed in ALDH
hi myoblasts. (c) DEAB (50 mM) treatment of ALDH
hi
murine myoblasts significantly decreased their proliferative rate in the absence of oxidative stress compared to untreated ALDH
hi myoblasts. (d)
However, DEAB treatment had no statistically significant effect on the oxidative stress (H2O2, 250 mM) resistance of ALDH
hi myoblasts in terms of
proliferation with the exception of an isolated data point at 24 hrs (p=0.034).
doi:10.1371/journal.pone.0029226.g003
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hi and ALDH
lo sorted murine MDSCs do not display
a difference in stress resistance, proliferation,
differentiation, and muscle regeneration capacity
Given the heterogeneity of ALDH activity and stress resistance
in myoblasts, we hypothesized that such heterogeneity may not be
observed in MDSC populations since we have previously reported
that MDSCs are highly resistant to stress [9]. ALDH
lo and
ALDH
hi subpopulations of murine MDSCs were isolated by
FACS in the same manner as murine myoblasts as depicted in
Figure 5a. A representative FACS isolation of ALDH
lo and
ALDH
hi MDSCs is illustrated in Figure 5b.
In contrast to myoblasts, MDSCs did not display a high degree
of heterogeneity in stress resistance behavior when sorted into
ALDH
lo and ALDH
hi subpopulations. No significant differences
in proliferation (Figure 5c, d) or myogenic differentiation
(Figure 5e-g) capacity under conditions of oxidative and
inflammatory stress were observed between ALDH
lo and ALDH
hi
MDSCs. Although a perceptible trend of an increase in the
myogenic differentiation index was observed in ALDH
hi MDSCs
when compared to ALDH
lo MDSCs, these trends were not
statistically significant except at one very high oxidative stress dose
(H2O2, 500 mM) and one intermediate inflammatory stress dose
(TNF-a, 1 ng/ml). While these trends suggest that there may be a
slight difference in stress resistance between ALDH
hi and ALDH
lo
MDSCs, these trends were not consistently statistically significant.
When injected intramuscularly into the mdx mouse gastrocne-
mius, both ALDH
lo and ALDH
hi MDSC subpopulations induced
robust muscle regeneration and formation of numerous dystrophin
expressing muscle fibers; however, no significant difference in the
RIs of ALDH
lo and ALDH
hi MDSCs was observed (Figure 5h, i).
Not surprisingly, there were no significant differences observed in
the GSH or SOD levels between the two ALDH sorted
subpopulations of MDSCs (Figure 5j, k). This result suggests that
no obvious difference in stress resistance, proliferation, myogenic
differentiation, or regenerative capacity in skeletal muscle exists
between ALDH
lo and ALDH
hi subpopulations of MDSCs, a
population of muscle cells endowed with a high resistance to stress
[9].
Increased stress resistance, proliferation, differentiation
and muscle regeneration capacity of ALDH
hi sorted
human muscle derived cells
Given the clinical relevance of working with human muscle
derived cells, we proceeded to study unfractionated or primary
hMDCs to determine whether their ALDH sorted subpopulations
would exhibit similar behavior to murine muscle derived cells. We
sought to identify a similar ALDH
hi subpopulation of cells from
cultured human primary cells using the same methodology
described for murine myoblasts and MDSCs (Figure 6a). Indeed,
the behavior of hMDCs sorted on the basis of ALDH activity
demonstrated many similarities to murine myoblasts in terms of
differences in stress resistance in vitro as well as regeneration
indices in vivo.
A dramatic increase in oxidative and inflammatory stress
resistance was observed in terms of proliferation and myogenic
differentiation in ALDH
hi hMDCs compared to ALDH
lo hMDCs.
A significant proliferation advantage of ALDH
hi hMDCs com-
pared to ALDH
lo hMDCs was observed (Figure 6b, c) when
exposed to either oxidative or inflammatory stress conditions.
Similarly, a significantly increased MDI was observed in ALDH
hi
hMDCs compared to ALDH
lo hMDCs at all oxidative and
inflammatory stress doses.
In vivo, a significantly increased RI was observed in the
gastrocnemius muscles of mdx/SCID mice transplanted with
ALDH
hi hMDCs compared to those injected with ALDH
lo and
unsorted hMDCs (Figure 6g-h). As in the case of ALDH sorted
murine myoblasts, we observed a strong correlation between stress
resistance in vitro with regeneration capacity in vivo.
To determine if the increased stress resistance capacity of the
ALDH
hi hMDCs may be conferred by elevated intracellular
Figure 4. Chondrogenic and osteogenic potential of ALDH
hi myoblasts. (a–c) Chondrogenic differentiation in ALDH sorted myoblasts was
induced via a pellet system containing TGF. Rapid proliferation and chondrogenic pellet formation was observed in ALDH
hi myoblasts (24 hrs) with
robust production of glycosaminoglycans (GAGs), visualized via Alcian blue staining. This is in contrast to the poor proliferation and GAG production
of ALDH
lo myoblasts. This result suggests that the chondrogenic differentiation capacity of unsorted myoblasts is dominated by ALDH
hi myoblasts.
(d–f) Osteogenic differentiation of ALDH sorted myoblasts was induced in vitro by BMP-4 stimulation. Alkaline phosphatase levels (ALP, shown in
blue), an early marker of osteogenic differentiation were significantly increased in ALDH
hi myoblasts compared to ALDH
lo myoblasts after a period of
4 d of BMP-4 stimulation.
doi:10.1371/journal.pone.0029226.g004
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hi MDSCs. (a) A schematic of the isolation of ALDH
lo and ALDH
hi subpopulations of
MDSCs is depicted here. (b) As discussed previously, ALDH
lo and ALDH
hi MDSCs were isolated, by excluding propidium iodide stained dead cells, and
forming appropriate ALDH gates using DEAB inhibited controls. (c, d) No statistically significant difference in proliferative capacity between ALDH
lo
and ALDH
hi MDSCs in oxidative stress (H2O2, 250 mM) or in inflammatory stress (TNF-a, 2.5 ng/ml) was observed (n=9). (e) ALDH sorted MDSCs
underwent myogenic differentiation in oxidative stress (H2O2, 250 mM) by expressing myosin heavy chain (MHC) and fusing into MHC
+ clusters (red)
rather than fusiform myotubes. (f, g) Significant differences in myogenic differentiation indices (MDI) were not observed in ALDH
hi MDSCs compared
to ALDH
lo MDSCs except at one very high oxidative stress (H2O2, 500 mM) and at an intermediate inflammatory stress level (TNF-a, 1 ng/ml) (n=9,
* indicates p,0.05). (h) Robust engraftment of ALDH
lo and ALDH
hi MDSCs was observed following intramuscular injection into the gastrocnemius of
mdx mice. Dystrophin (DYS) positive myofibers (stained in red) indicate transplanted MDSC myofiber generation or fusion with a host myofiber. (i) No
statistically significant differences in regeneration index were observed in ALDH
hi transplanted mice compared to those injected with ALDH
lo and
unsorted MDSCs (n=3). (j, k) Measurements of intracellular antioxidant levels in terms of glutathione (GSH) and superoxide dismutase (SOD) levels
yielded no statistically significant differences between ALDH
lo and ALDH
hi MDSCs (n=3).
doi:10.1371/journal.pone.0029226.g005
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hi myoblasts, we examined the GSH and
SOD levels in ALDH
lo and ALDH
hi hMDCs. Although a trend of
increased GSH was observed in ALDH
hi hMDCs compared to
ALDH
lo hMDCs, this trend was not statistically significant
(Figure 6i). However a significant difference in intracellular SOD
wasobservedbetweentheALDH
hiandALDH
lo hMDCs(Figure 6j).
Again, an association of elevated ALDH activity with elevated
intracellular antioxidant levels suggests a mechanism by which these
cells are able to withstand oxidative and inflammatory stress
conditions, above that which may be conferred by ALDH itself.
Discussion
Our research on the muscle regenerative capacity of various
populations of myogenic progenitors suggests that stress resistance
is predictive of muscle regeneration capacity [9,10,11]. Following
transplantation, precipitous and acute cell loss is observed which
has been attributed to inflammation, anoikis, and ischemia [66].
The conditions that donor cells encounter upon transplantation
are deleterious to survival and tissue specific differentiation, due to
the host inflammatory process initiated within minutes of
transplantation. This exposes the cells to oxidants such as H2O2,
cytotoxic radicals, and pro-inflammatory cytokines [67]. In the
24–48 hrs following transplantation, cell competence in terms of
survival, proliferation, and myogenic differentiation largely
determines efficacy of subsequent skeletal muscle regeneration.
We have shown that by modulating the antioxidant levels of
MDSCs we can alter its skeletal muscle regenerative capacity both
in cardiac and skeletal muscle [9,11]. Similar studies using
antioxidant and anti-inflammatory treatments such as SOD-
Figure 6. Isolation and stress resistance capacity of ALDH
hi human muscle derived cells (hMDCs). (a) ALDH
hi hMDCs were isolated using
FACS. (b, c) Significantly increased rates of proliferation of ALDH
hi hMDCs compared to ALDH
lo hMDCs were observed in conditions of oxidative
(H2O2, 250 mM) and inflammatory stress (TNF-a, 2.5 ng/ml) (n=6, * indicates p,0.05). (d) Myogenic differentiation capacity was measured in low
serum conditions by myosin heavy chain (MHC, shown in red) expression. ALDH
hi hMDCs generated dense networks of MHC
+ myotubes in oxidative
stress conditions (H2O2, 250 mM) in contrast to ALDH
lo hMDCs. (e, f) Significantly increased myogenic differentiation indices (MDI) were calculated in
ALDH
hi hMDCs in oxidative (H2O2) and inflammatory (TNF-a) stress conditions compared to ALDH
lo hMDCs. (g, h) Dystrophin (DYS, red) positive
myofiber regeneration was observed following intramuscular injection of ALDH sorted hMDCs. A significantly increased regeneration index was
observed in ALDH
hi hMDC transplanted mdx/SCID mice compared to those injected with ALDH
lo and unsorted hMDCs (n=3). (i) While a trend of
increased GSH levels was observed between ALDH
hi and ALDH
lo hMDCs, this increase was not statistically significant. (j) However, significantly
increased superoxide dismutase (SOD) activity was observed in ALDH
hi hMDCs when compared to ALDH
lo hMDCs (n=3).
doi:10.1371/journal.pone.0029226.g006
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further demonstrate the importance of stress resistance in the
context of cell survival in cell therapy. While numerous
immunosuppressive and antioxidant modalities have been identi-
fied to increase cell survival following transplantation, cellular
candidates for transplantation may also be screened for or isolated
by their inherent survival capabilities [66,70]. It is this approach
that has motivated the present study as well as other ongoing
studies in our group.
The role of ALDH on the stress resistance and
differentiation capacity
In the current study, ALDH
hi muscle progenitor cells isolated
by FACS from murine and human skeletal muscle demonstrated
an enhancement in cell proliferation and myogenic differentiation
capacities, when cultivated in conditions of oxidative (H2O2) and
inflammatory stress (TNF-a). Vauchez et al. and Jean et al. have
previously isolated ALDH
hi progenitors from human muscle
[16,37]. However, Jean et al. found ALDH
hi cells to be absent
in murine muscle, despite the isolation of ALDH
hi cells from other
murine tissues by others [37,71]. The source of the difference in
our observations is not entirely clear, however it may lie in part in
differences our isolation protocols. Jean et al. studied the cells
isolated by FACS immediately following pronase digestion of
murine paw muscles; however, the age and sex of their animals
were not cited [37]. Our use of muscle from neonatal female mice,
which we have found to be enriched with stem cells, and our use of
the preplate technique prior to FACS isolation may account for
the difference in our observations [12,37].
While ALDH has been shown to mitigate oxidative damage
such as lipid peroxidation, our results indicate that increased
intracellular antioxidant levels observed in ALDH
hi cells are
primarily responsible for the increased oxidative stress resistance.
This conclusion is not entirely consistent with the findings of Jean
et al. who observed a dramatic loss in viability of human ALDH
hi
myoblasts in oxidative stress when ALDH activity was inhibited by
DEAB [37]. However we observed no loss in proliferative capacity
when murine ALDH
hi myoblasts were treated with DEAB. The
difference in our observations however likely stems from
differences in our experimental design. Jean et al. used survival
as their metric of oxidative stress resistance, whereas we measured
proliferation, which clearly employs different cellular pathways
and may have a different sensitivity of oxidative stress. Jean et al.
observed differences in survival at H2O2 concentrations of 400–
650 mM, far greater than the concentration we required (250 mM)
to observe differences in proliferation. We concluded that ALDH
activity likely plays a role but does not represent a major
determinant in the oxidative stress capacity of ALDH
hi cells.
However, increased reservoirs of intracellular antioxidants such as
GSH and SOD in murine and human ALDH
hi murine myoblasts
and hMDCs appear to have a greater impact on oxidative stress
resistance than ALDH activity.
ALDH mediated production RA has been shown to promote
myogenic differentiation but play a more nuanced or synergistic
role in osteogenic and chondrogenic differentiation [59,62,63,
72,73,74]. The increased myogenic differentiation capacity of both
ALDH
hi murine myoblasts and hMDCs in the absence of H2O2
and TNF-a suggests an inherent elevated myogenic capacity
compared to their ALDH
lo counterparts, clearly implicating the
RA producing activity of ALDH. These results are corroborated
by those of Vauchez et al., who observed increased myogenic
capacity of ALDH
hi human myoblasts [16]. However, elevated
RA cannot account for the preservation of this myogenic capacity
at increasing stress doses observed in our paper. This must be
mediated, again, by the increased antioxidant capacity of ALDH
hi
cells as discussed previously. This conclusion is reinforced by the
observation that ALDH
lo myoblasts, while capable of myogenic
differentiation, lose this capacity rapidly with increasing stress
doses.
RA has been shown to promote osteogenesis synergistically with
bone morphogenic protein [61,73]. This suggests that ALDH
hi
myoblasts may be expected to have increased osteogenic
differentiation compared to ALDH
lo myoblasts when treated with
BMP-4 as we observed in our murine muscle derived cells.
Vauchez et al. also observed osteogenic differentiation in their
ALDH
hi human cells however they did not compare this capacity
to their ALDH
lo cells [16]. Although some authors have shown
RA to impair chondrogenesis others have shown that it is required
for chondrogenesis but only at certain points in chondrogenic
differentiation [62,63] Therefore one would not necessarily expect
ALDH
hi cells to undergo chondrogenesis at an enhanced rate
compared to ALDH
lo cells. However, we observed not only
increased proliferation in chondrogenic media but also increased
GAG production by ALDH
hi myoblasts. In this case the RA does
not necessarily have a role in promoting chondrogenesis and
almost certainly does not have a role in promoting proliferation in
this setting. We posit that this result may simply be explained by
an increased capacity of these cells to survive the chondrogenic
and osteogenic media conditions, given the poor proliferation of
ALDH
lo myoblasts in chondrogenic media and inability to form a
dense chondrogenic pellet.
ALDH activity in MDSCs: Implications on the preplate
technique
We observed an enrichment of ALDH
hi cells in late preplate
cells (slowly adhering cells), a population enriched with MDSCs
which exhibit elevated oxidative stress resistance [9]. It is possible
that the preplate technique segregates cells based on their ability to
remain viable in suspension and resist detachment induced
apoptosis or anoikis [75]. Given our observation, of an enrichment
of SACs in ALDH
hi murine muscle derived cells (Figure 1e),
perhaps the enhanced survival of these cells includes increased
resistance to anoikis. These results suggest that the yield of the
preplate technique could be improved or the process shortened to
fewer preplate cycles if it is preceded by FACS isolation of
ALDH
hi cells.
No improvement in stress resistance was observed in ALDH
hi
MDSCs compared to ALDH
lo MDSCs in terms of proliferation
and myogenic differentiation. This result is not surprising given the
increased homogeneity of MDSCs in addition to previous
observations of increased stress resistances in MDSCs in general
compared to myoblasts [9]. These experiments demonstrate that
the stress resistance of MDSCs is not further enhanced by isolating
an ALDH
hi sub-population.
Implications of in vitro behavior on muscle regeneration
in vivo
The improved proliferative capacity of murine ALDH
hi
myoblasts and hMDCs over that of their ALDH
lo counterparts,
in the presence of H2O2 and TNF-a in vitro suggests that the
ALDH
hi cells may have an increased proliferative capacity under
conditions of post-transplantation inflammation in vivo. Similarly,
an increased differentiation capacity in conditions of oxidative and
inflammatory stress is likely to translate to an improvement in the
differentiation capacity when the cells are exposed to post-
transplantation inflammation. Indeed we observed improved
muscle regeneration in muscles injected with both murine or
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hi muscle cells compared to their ALDH
lo
counterparts, which appears to be a function of improved survival,
proliferation, and myogenic differentiation.
The source of this improved regeneration capacity of ALDH
hi
myogenic cells may be increased stress resistance, due to the
elevated intracellular levels of antioxidants such as GSH and SOD
in addition to the stress resistance role of ALDH, an observation
that was also made previously in MDSCs [9]. The finding that
increasing the antioxidant levels of ALDH
lo myoblasts by treating
them with XJB improved their proliferative capacity to a similar
level observed in the ALDH
hi myoblasts supports this hypothesis.
Furthermore, decreasing the GSH antioxidant levels of ALDH
hi
myoblasts via DEM treatment inhibited their proliferative capacity
to a similar level observed in the ALDH
lo myoblasts.
While numerous myogenic cells have been identified for muscle
cell therapies, identification of definitive or even desirable markers
for myogenic progenitor isolation remains elusive [5]. In our
experience, a common feature of myogenic progenitors with high
regeneration potential lies in their increased resistance to oxidative
and inflammatory stress [9,10]. In the current study, we isolated
ALDH
hi and ALDH
lo subpopulations of cultured murine
myoblasts and MDSCs in addition to hMDCs. The utility of
isolating myogenic cells with elevated ALDH expression is two-
fold. Myogenic progenitors may be rapidly isolated from
heterogeneous populations of muscle derived cells using a simple
intracellular dye, Aldefluor. In addition, ALDH may be used as a
marker to identify cells with an increased proliferative and
differentiation capacity when exposed to oxidative and inflamma-
tory stress.
Although it has been known for many years that stem and
progenitor cells display unique behaviors that are advantageous to
applications of cell therapy such as self-renewal, long-term
proliferation, and multipotent differentiation, our results suggest
that resistance to stress should be included among these vital
attributes. Stem cell behavior such as improved survival may even
represent a more important ‘‘marker’’ for stem cell therapy than
the use of traditional surface marker profiles. This particular
hypothesis is supported by our extensive studies of MDSCs, which
are isolated by their slow adhesion behavior and their remarkable
survival capacity in vitro and in vivo [9,17,76,77]. In our
continued work, we seek a greater understanding of the
mechanisms responsible for increased regeneration capacity and
an understanding of what allows some progenitors greater survival
abilities in the presence of oxidative and pro-inflammatory
environments. The data presented in this study suggests that
ALDH can be used as a marker to identify progenitors that are not
only myogenic but have elevated oxidative and inflammatory
stress resistance.
Materials and Methods
Animal usage
All animal procedures were performed in accordance with the
Guide for the Care and Use of Laboratory Animals (NIH
Publications 85-23) as promulgated by the Committee of Care and
Use of Laboratory Animals of the Institute of Laboratory Sciences,
the National Academy of Sciences, and the National Research
Council. The University of Pittsburgh’s Institutional Care and Use
Committee (IACUC) reviewed and approved all the procedures
performed in these studies (IACUC protocol #: 0902596A-2).
Murine cell isolation
Murine myoblasts and MDSCs were isolated from the skeletal
muscle of 3-wk-old C57BL/6J female mice (The Jackson
Laboratory, Bar Harbor, ME) as previously described using a
modified preplate technique [12,17]. Muscle extracted from
hindlimbs were minced into a slurry and enzymatically dissociated
at 37uC in 0.2% collagenase-type XI (Sigma-Aldrich) for 1 hr.
The cells were then incubated in dispase (2.4 U/ml HBSS,
GIBCO, Invitrogen) for 45 min then for 30 min in trypsin-EDTA
(0.1% in HBSS, GIBCO, Invitrogen). The dissociated cells were
passed through a 70 mm filter, centrifuged and resuspended in
proliferation medium (PM) to initiate the preplate process. PM
consists of 10% horse serum (GIBCO), 10% FBS (GIBCO), 0.5%
chick embryo extract (Accurate Chemical Company), and 1%
penicillin–streptomycin (GIBCO) in DMEM high glucose (In-
vitrogen).
The preplate technique segregates muscle derived cell popula-
tions by how quickly they adhere to collagen-coated plates as
described elsewhere [12,76]. Briefly, cells are plated on collagen-I
coated plates for a predetermined amount of time (PP1: 2 hrs,
PP2-PP6: 24 hrs) at which point non-adherent cells are collected,
centrifuged and plated for the next preplate cycle, as depicted in
Figure S1a. Each preplate population has been previously
characterized, such that each subsequent preplate cycle is enriched
with myogenic, desmin-positive cells [50,78,79]. MDSCs are
isolated from long-term proliferating colonies of PP6.
Myoblasts were isolated from rapidly adhering cell fractions of
the early preplate cycles while MDSCs were isolated from the
slowly adhering cell fraction of the late preplate cells (PP6). All
cells were cultured and expanded in PM in collagen-coated flasks
at 37uC and 5% CO2 as described previously [12]. When
applying the preplate technique to ALDH sorted cells (as shown
in Figure 1e), the digestion process was identical to that
described above; however, the digested muscle cells were sorted
for ALDH activity using FACS prior to performing the preplate
protocol.
Human muscle cell isolation
Human gastrocnemius muscle biopsies, 9 in total, were obtained
(mean age 58 years; range 25 to 75 years, both male and female)
from the National Disease Research Interchange (NDRI) and the
Center for Organ Recovery and Education (CORE). All biopsies
were taken from patients with no history of neuromuscular/
skeletal disease, sepsis, chemotherapy, drug abuse, or ventilatory
support greater than 1 month. Furthermore, NDRI and CORE
obtain written informed consent from the patient’s family prior to
harvesting any organs or tissues. Acquisition of muscle from the
NDRI and CORE, and subsequent muscle stem cell isolation, was
performed in accordance to the protocol reviewed and approved
by the University of Pittsburgh’s Institutional Review Board
(Protocol #: PRO09030265, entitled: Isolation of Human Muscle-
Derived Stem Cells). Tissue was finely minced then digested for
60 min at 37uC with 2.4 U/mL dispase (GIBCO), type-I and
type-IV collagenases (both at 0.5 mg/ml; Sigma-Aldrich). The
digested tissue was pelleted and resuspended in DMEM
supplemented with 10% fetal bovine serum (FBS) and 1%
penicillin/streptomycin (P/S), then passed through a 100 mm
filter followed by a 70 mm filter to obtain a single cell suspension.
Cells were then treated with red cell lysis buffer for 15 minutes
before being cultured in PM in collagen-I coated flasks at 37uC
and 5% CO2. PM consists of 10% horse serum (GIBCO), 10%
FBS (GIBCO), 1% chick embryo extract (Accurate Chemical
Company), and 1% penicillin–streptomycin (GIBCO) in DMEM
high glucose (Invitrogen). Following enzymatic dissociation,
human muscle cells were cultured for three to four days in the
flasks of their original seeding and were passaged one to two times
as necessary prior to FACS. This protocol is illustrated in Figure
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CD56 positive, indicating their myogenic lineage (data not shown).
Fluorescence activated cell sorting by ALDH activity
Cultured murine and human cells were trypsinized, washed in
cold PBS, and counted using a hemocytometer. Cells (10
6) of each
population were resuspended in Aldefluor buffer, which contains
an ABC transport inhibitor that prevents efflux of the Aldefluor
dye, and incubated at 37uC with BAAA according to the
manufacturer’s instructions (Aldagen Inc, Durham, NC). Cells
were washed in Aldefluor buffer and maintained in 4uC
throughout the cell sorting process. ALDH activity was assessed
using the FL1 channel of a BD FACSAria Cell Sorting System and
FACSDiva software (version 6.1.2) (Becton, Dickinson and
Company, San Jose, CA). Collected cells were gated on their
fluorescence intensity, which corresponds to their ALDH activity
levels, as well as low side scatter (SCC
lo). Sorted cells were
recaptured in cold (4uC) PM and immediately plated in collagen-I
coated flasks and normal incubation conditions (5% CO2 at 37uC).
In vitro proliferation capacity
Time-lapse live cell microscopy was employed to monitor the
rate of proliferation under conditions of oxidative and inflamma-
tory stress [80,81]. Sorted human muscle derived cells were plated
in collagen-I coated 24-well plates at an initial density of 1000
cells/cm
2 in PM and incubated under normal conditions for
24 hrs. The media was exchanged with PM treated to simulate
oxidative (250 mM, H2O2, Sigma-Aldrich) and inflammatory stress
(2.5 ng/ml, TNF-a, both mouse and human recombinant, R&D
Systems) and immediately placed in a live cell imager. Cells were
imaged at 30 min intervals in three 106microscope fields per well
over a 48 hr time period under normal incubation conditions (5%
CO2 at 37uC).
In vitro muscle differentiation capacity
The capacity of ALDH sorted cell populations to differentiate
into MHC expressing cells under varying conditions of oxidative
and inflammatory stress was quantified in vitro using the MDI
metric. Cells were plated at 1000 cells/cm
2 in 24-well plates for
2 d in PM or until near confluence. PM was then exchanged for
differentiation media (DM; 2% HS, 1% P/S in DMEM) treated to
simulate oxidative stress (25 mM, 100 mM, 250 mM, and 500 mM,
H2O2, Sigma-Aldrich) and inflammatory stress (1 ng/ml, 2.5 ng/
ml, and 5 ng/ml, TNF-a, R&D Systems). The media was
exchanged daily to maintain constant stress levels [9]. Cells were
allowed to differentiate and fuse for 4 d then fixed with cold
methanol (220uC). The MDI was quantified via immunohisto-
chemical staining for MHC expression as described in ‘‘Immuno-
histochemistry’’ methods section.
Antioxidant capacity
The antioxidant capacity was measured in terms of the activity
of the major intracellular antioxidant molecules: GSH and SOD.
Levels of GSH were measured colorimetrically (Calbiochem,
354102) using a spectrophotometer (TECAN Infinite M200,
Ma ¨nnedorf, Switzerland). GSH detection is mediated by capture
of all thiol mercaptans (RSH) from mechanically homogenized
cells into thioethers by 4-chloro-1-methyl-7-trifluromethyl-quino-
linium methylsulfate followed by the formation of a chromophoric
thione in those GSH specific thioethers using NaOH. GSH levels
were quantified by chromophoric thione absorbance at 400 nm.
Total activity of SOD was measured using a colorimetric assay
(Chemicon, Temecula, CA; APT290). SOD levels of chemically
lysed cells (10 mM Tris, pH 7.5, 150 mM NaCl, 0.1 mM EDTA,
and 0.5% Triton X-100) were measured using a xanthine/
xanthine oxidase system in which superoxide-chromagen absor-
bance (490 nm) is lowered by the presence of SOD.
The intracellular antioxidant levels of ALDH
lo and ALDH
hi
myoblasts were modified by a chemical antioxidant (XJB-5-131,
generously donated by Prof. Peter Wipf at the University of
Pittsburgh) and DEM, a pro-oxidant (Sigma-Aldrich). XJB is a
membrane permeable, mitochondrial targeted nitroxide antioxi-
dant that has proven to be cytoprotective in disease states
associated with oxidative stress, such as hemorrhagic shock, and
mitigates apoptotic cell death in vitro [82,83]; whereas DEM, is a
chemical that conjugates and inactivates GSH thus decreasing the
cell’s capacity to resist oxidative stress [84]. To examine the role of
antioxidant levels in ALDH sorted myoblasts, ALDH
lo myoblasts
were pretreated with 500 nM XJB in PM for 2 hrs prior to
exposure to oxidative stress (250 mMH 2O2 in PM) conditions.
ALDH
hi myoblasts were pretreated with 50 mM DEM for 2 hrs
prior to exposure to oxidative stress (250 mMH 2O2 in PM)
conditions. In both cases the myoblasts were washed in PBS prior
to stress exposure to insure all active antioxidants or pro-oxidants
were intracellular and not in the media. The rates of proliferation
and survival of these pretreated myoblasts were quantified using a
live cell imager (Kairos Instruments LLC, Pittsburgh, PA) and
compared to that of non-pretreated controls in identical oxidative
stress conditions.
To examine the role of ALDH in the antioxidant capacity of
ALDH sorted myoblasts a potent ALDH inhibitor, DEAB, was
used. Pretreatment of ALDH
hi myoblasts with 50 mM of DEAB in
PM was used 24 hrs prior to oxidative stress exposure. A
concentration of 50 mM DEAB was maintained during the
oxidative stress exposure to maintain ALDH inhibition throughout
the experiment. The rates of proliferation and survival were
quantified using a live cell imager and ImageJ software (NIH).
Skeletal muscle regeneration capacity
Skeletal muscle regeneration capacity of ALDH sorted myo-
genic cells was quantified using the regeneration index metric as
previously described [9,17,51]. Briefly, the number of dystrophin
positive myofibers per cryosection per 10
5 cells injected is
recorded. ALDH sorted murine cells were injected into the
gastrocnemius muscles of female mdx mice (C57BL/10ScSn-
DMD
mdx/J, The Jackson Laboratory), which is a murine model of
Duchenne muscular dystrophy using a protocol previously
described [9,85]. The mdx mouse is a C57BL strain homozygous
for a spontaneous X-linked mutation of the dystrophin gene and
lacks dystrophin protein expression [85]. Animals were sacrificed
14 d following injection. ALDH sorted human muscle cells were
injected into the gastrocnemius muscles of male mdx/SCID mice
(C57BL/10ScSn-DMD
mdx-SCID/J, The Jackson Laboratory)
aged 6–8 weeks using a protocol previously described [10]. Cells,
cultured in T-175 collagen-I coated flasks, were trypsinized,
counted, washed in cold PBS, and resuspended in a cold PBS
suspension of FluoSpheres (Molecular Probes), at a concentration
of 2610
6 cells per 20 ml, prior to injection. Animals were sacrificed
at 10 d after injection to conform to previous human cell
transplantation experiments in our lab [10]. All gastrocnemius
muscles were excised and frozen in 2-methyl-butane, cryosec-
tioned (8 mm), and mounted on glass slides.
Immunohistochemistry
Differentiation of myogenic cells into MHC expressing cells in
vitro was quantified using the MDI metric described previously.
Briefly, samples were blocked with 5% HS and incubated with
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conjugated anti-mouse antibodies. Nuclei were stained blue with
4, 6-diamidino-2-phenylindole (DAPI, Sigma; 100 ng/ml, 1:1000).
At least 200 cell nuclei were counted for each MDI measurement.
All murine skeletal muscle tissue samples were frozen in 2-
methylbutane cooled in liquid nitrogen, then stored at –80uC.
8 mm cryosections were fixed in 5% formalin for 2 min and
blocked in 5% donkey serum for 1h. Skeletal muscle sections were
stained for dystrophin (DYS) using an anti-dystrophin primary
antibody (1:300, Rabbit Anti-DYS, Abcam Ab15277) and a
secondary anti-rabbit antibody (1:500, Donkey anti-Rabbit,
Molecular Probes A21207) using a protocol previously described
[86]. Nuclei were stained with DAPI. Fluorescence and brightfield
microscopy was performed using a Nikon Eclipse E800 micro-
scope (Melville, NY) equipped with a Retiga Exi digital camera
(QImaging) and Olympus FV 500 confocal scanning microscope.
All images were acquired and analyzed using Northern Eclipse
software (version 6.0; Empix Imaging).
Osteogenic and chondrogenic differentiation
ALDH
hi, ALDH
lo and unsorted cells were prepared in pellet
form (2.5610
5 cells) or as a monolayer (1.5610
4 cells/well in 12
well plates). For osteogenesis, murine myoblasts were plated on
collagen-I coated 12 well plates and maintained for 4 d in
osteogenic media (Lonza, Walkersville, MD), which included
dexamethasone, glutamine, ascorbate, penicillin/streptomycin (P/
S), b-glycerophosphate and bone morphogenic protein-4 (50 ng/
ml). The cells were stained for alkaline phosphatase following the
manufacturer’s instructions (Sigma-Aldrich, 86C-1KT). Chondro-
genesis of murine myoblasts was studied by culturing the cells in a
pellet culture by incubating the cell pellets for 21 d in
chondrogenic media (Lonza, PT3003), which contains dexameth-
asone, ascorbate, ITS+, P/S, sodium pyruvate, proline, glutamine
and TGF-beta-3 (10 ng/ml) (Lonza, PT4124). All pellets were
fixed in 10% formalin for 24 hrs followed by dehydration, paraffin
embedding, sectioning, and Alcian blue staining.
Statistical Analysis
Data are expressed as a mean with its standard deviation. Direct
comparisons between two cell populations were made using an
unpaired, two-tailed Student’s t-test, where p,0.05 was consid-
ered to be statistically significant. Comparisons of multiple groups
were completed using one-way ANOVA followed by Tukey post-
hoc comparisons.
Supporting Information
Figure S1 Isolation diagram of murine and human
ALDH sorted cells. (a) Murine myoblasts and MDSCs were
isolated by a modified preplate technique, as described previously.
ALDH
hi and ALDH
lo subpopulations of these muscle derived cells
were isolated by FACS for subsequent expansion in proliferation
medium. (b) hMDCs were isolated by enzymatic digestion of
human skeletal muscle. Following 3-4 d of culture, ALDH
hi and
ALDH
lo subpopulations of hMDCs were isolated by FACS for
subsequent expansion in proliferation medium.
(TIF)
Table S1 Data summary of ALDH sorted populations
isolated from skeletal muscle.
(TIFF)
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